🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Exergaming Revolution in Dementia

RecruitingNAAges any - anyAllEastern Switzerland University of Applied Sciences
NCT06631742 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This pilot randomized controlled trial evaluates the effect of a 12 weeks exergaming training in people with major neurocognitive disorders (MNCD) living in long-term care facilities.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Neurocognitive disorder based on Alzheimer's Disease, Parkinson's disease, Lewy body dementia or Mixed dementia according to the criteria of the American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5) * Mini-Mental-Status-Examination (MMSE) Score of ≥5 and ≤26 out of e maximum of 30 Exclusion Criteria: * MMSE \<5 * Unstable cardiovascular condition or other medical condition that does not allow for safe participation according to the recommendations of the American College of Sports Medicine * Planned transfer to another facility within the next 3 months * Acute behavioural problems
💊

What it tests

  • Exergaming on Dividat Senso
  • Usual Care
📍

Where

1 site
Sonnweid AG
Wetzikon, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy